01.01.2015 Views

Vol 31, Part I - forums.sou.edu • Index page - Southern Oregon ...

Vol 31, Part I - forums.sou.edu • Index page - Southern Oregon ...

Vol 31, Part I - forums.sou.edu • Index page - Southern Oregon ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

ABSTRACTS – Symposia<br />

in the presence of numerous inhibitors that target host cell<br />

signaling proteins. We then measured the number of host<br />

cell-internalized bacteria and levels of IL-8 secreted into the<br />

supernatants.<br />

We found that many of the host cell proteins required for<br />

C. jejuni internalization and the IL-8 inflammatory response<br />

are the same (i.e., EGFR, FAK, Src, PI 3-kinase). We also<br />

identified a C. jejuni secreted protein, which we termed CiaD,<br />

that activates the mitogen-activated protein kinase (Erk 1/2)<br />

pathway necessary for the secretion of IL-8 from epithelial<br />

cells. These findings are consistent with the proposal that the<br />

C. jejuni Cia proteins promote intracellular signaling leading<br />

to bacterial uptake and the release of the pro-inflammatory<br />

cytokine IL-8.<br />

85 Effects of Selective and Non-selective NSAIDs on Initiation,<br />

Progression and Antibiotic Efficacy of Experimental<br />

Group A Streptococcal Myonecrosis, Stephanie Ham-<br />

ILTON 1,2 *, Clifford R Bayer 1 , Dennis L Stevens<br />

1,3 , and Amy E Bryant 1,2,3 ( 1 U.S. Department<br />

of Veterans Affairs Medical Center, 500 West Fort Street,<br />

Boise, ID 83702; 2 University of Idaho, Department of Life<br />

Sciences, PO Box 443051, Moscow, ID 83844-305; 3 University<br />

of Washington School of Medicine, 1959 NE Pacific<br />

Street, Seattle WA 98195; hamilton.steph@yahoo.com).<br />

Background: NSAIDs may worsen group A streptococcal<br />

(GAS) disease yet some advocate NSAIDs to treat<br />

bacterial infection. We examined the effects of selective<br />

and non-selective NSAIDs, alone and with antibiotics, on<br />

initiation of post-injury GAS muscle infection and on survival<br />

of mice with GAS myonecrosis. Methods: Wild-type<br />

or COX-2 -/- mice underwent standardized hindlimb muscle<br />

injury. NSAIDs were given 47 hr post-injury and 1 hr prior<br />

to IV M-type 3 GAS. GAS in muscles, blood and spleen was<br />

quantitated 6 hrs later. In separate studies, mice were infected<br />

IM with LD 100<br />

GAS. NSAIDs and/or antibiotics (penicillin,<br />

clindamycin) were given every 8-12 h for 72 hr. Survival was<br />

followed for 14 d. Results: The non-selective NSAID significantly<br />

increased GAS infection of injured muscle in only<br />

wild-type mice. Pharmacologic inhibition, but not genetic<br />

deletion, of COX-2 r<strong>edu</strong>ced the systemic bacterial burden<br />

below the muscle infection threshold. In established myonecrosis,<br />

non-selective and COX-2-selective NSAIDs significantly<br />

accelerated the time to death and greatly r<strong>edu</strong>ced antibiotic<br />

efficacy. Conclusions: We conclude that use of certain<br />

NSAIDs, either alone or as adjuncts to traditional antibiotic<br />

therapy, for suspected or established GAS infection is not<br />

prudent and may, in fact, contribute to worse outcomes in<br />

severe GAS infection.<br />

86 Modeling HIV-1 Latency in Primary Central Memory Lymphocytes,<br />

Laura MARTINS*, ALBERTO Bosque,<br />

Marylinda Famigletti, Peter Ramirez,<br />

Camille Novis, and VICENTE Planelles<br />

(Division of Microbiology and Immunology, Department of<br />

Pathology, University of Utah, 15N Medical Dr., Salt Lake<br />

City, UT, 84112; laura.martins@path.utah.<strong>edu</strong>).<br />

Central memory CD4+ T lymphocytes (T CM<br />

) harbor the<br />

majority of latent HIV-1 proviruses in vivo. We have developed<br />

a latency assay based on cultured T CM<br />

cells to characterize<br />

biological processes important in the establishment<br />

and maintenance of HIV-1 latency. Using this model, we<br />

have characterized the effects of antigenic stimulation and<br />

homeostatic proliferation induced by cytokines on the latent<br />

reservoir. Antigenic stimulation through the TCR and the<br />

subsequent activation of the Lck/calcineurin/NFAT pathway<br />

reactivates virtually all latently infected cells, and successfully<br />

depletes the reservoir, but would result in cytokine<br />

storm if used in vivo. IL-2+IL-7 cytokine stimulation reactivates<br />

latently infected cells, albeit infefficiently, with concomitant<br />

expansion of the latent reservoir via homeostatic<br />

proliferation. Because both of these options are therapeutically<br />

untenable, we <strong>sou</strong>ght alternate approaches for reactivation<br />

of latent HIV-1.<br />

We adapted our published HIV-1 latency model for high<br />

throughput screening of compounds with the ability to reactivate<br />

latent HIV-1. One such compound, denoted “C7”, is<br />

capable of viral reactivation within 80% of latently infected<br />

cells, without global T cell activation. This result demonstrates<br />

the existence of alternative signaling pathways leading<br />

to activation of latent proviruses in primary cells. Key<br />

signaling elements controlling these pathways should be<br />

considered as novel therapeutic targets.<br />

Recent Advances in<br />

Pharmacology and Toxicology<br />

Wednesday, 8:30 a.m. in PAYETTE RIVER<br />

87 Inhibition of Growth of Cervical Cancer Cells by a<br />

Chymotrypsin-Like Protease Inhibitor, KIMBERLY J<br />

JURGENSEN*, KRISTIN A ECKERT, and GARY A<br />

CLAWSON (Jake Gittlen Cancer Research Foundation,<br />

Pennsylvania State University College of Medicine, H059,<br />

500 University Drive, Hershey, PA 17033; kim_jduncan@<br />

hotmail.com).<br />

The chymotrypsin-like serine protease inhibitor, succinyl-alanine-alanine-proline-phenylalanine<br />

chloromethyl<br />

ketone (AAPF CMK<br />

), has been shown to significantly inhibit<br />

the growth of tumorigenic human papillomavirus (HPV)-<br />

infected keratinocytes in organotypic raft cultures.. . We<br />

hypothesized that AAPF CMK<br />

treatment arrests the growth<br />

of the HPV-16 infected cervical cancer cell lines, SiHa and<br />

CaSki, by blocking the ability of the HPV-16 E6 and/or E7<br />

oncoproteins from interacting with the tumor suppressor proteins,<br />

p53 and pRb, respectively...The effects of AAPF CMK<br />

treatment on cellular growth, cell cycle kinetics, DNA synthesis,<br />

and p53 and pRb expression levels were examined in<br />

72

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!